scroll down
Global API CDMO Company
Walking with partners,
Creating value
Creating value
Technology-driven gene therapy CDMO
from oligonucleotide to xRNA
View our Science & TechnologyGlobal API CDMO Company
Walking with Partners, Creating Value
Walking with Partners, Creating Value
30+years
Track record
40+
Global CDMO Project
6.4mole
Oligo CDMO Capacity ('22)
1.0kg / year
mRNA CDMO Capacity
IR Library
- [IR Materials] mRNA Platform TechnologyMar 14, 2023
- [Analyst Report] 4Q review: Oligo-driven strengthFeb 17, 2023
- [Earnings Summary] ST PHARM 4Q. 2022 Earnings SummaryFeb 17, 2023
- [Presentation] ST PHARM IR Preentation (Feb. 2023)Feb 6, 2023
- [Analyst Report] Fundamentals intact despite noiseJan 16, 2023